Table 2.
Outcomes
| Outcome | Colistin, n (Rate per 100 d) | Control, n (Rate per 100 d) | IRR (95% CI) |
|---|---|---|---|
| AKI | |||
| End of follow-up | 77 (7.6) | 33 (2.6) | 2.9 (1.9 to 4.5) |
| 72 h | 30 (7.4) | 16 (3.8) | 1.9 (1.1 to 3.5) |
| Dialysis at end of follow-up | 4 (0.28) | 3 (0.20) | 1.4 (0.3 to 6.0) |
| AKI or death at end of follow-upa | 82 (8.0) | 39 (3.1) | 2.6 (1.8 to 3.9) |
IRR, incidence rate ratio; 95% CI, 95% confidence interval.
a
Seventeen patients died in the colistin group and seven patients died in the control group at the end of follow-up. Death was preceded by AKI in 12 and two patients in the colistin and control groups, respectively.